1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow AZD1613 - Part B: new trials by email Literature Review of AZD1613 - Part B trials Research Report on AZD1613 - Part B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease AZD1613 - Part A, Placebo - Part A, AZD1613 - Part B - Autosomal Dominant Polycystic Kidney Disease | Phase 1 | Recruiting | AstraZeneca | 40 | 2025-11-10 | 2026-10-13 |
Polycystic Kidney, Autosomal Dominant (1)
AstraZeneca (1)
China (1) · United Kingdom (1) · United States (1)